Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37 Sell
2
-17
-89% -$363 ﹤0.01% 4158
2026
Q1
$384 Hold
19
﹤0.01% 4015
2025
Q4
$364 Hold
19
﹤0.01% 4096
2025
Q3
$457 Hold
19
﹤0.01% 3955
2025
Q2
$369 Hold
19
﹤0.01% 3834
2025
Q1
$245 Hold
19
﹤0.01% 3783
2024
Q4
$327 Sell
19
-27
-59% -$540 ﹤0.01% 3710
2024
Q3
$1.04K Hold
46
﹤0.01% 3502
2024
Q2
$1.14K Hold
46
﹤0.01% 3442
2024
Q1
$1.51K Sell
46
-28
-38% -$953 ﹤0.01% 3432
2023
Q4
$2.69K Buy
74
+28
+61% +$961 ﹤0.01% 3285
2023
Q3
$1.69K Hold
46
﹤0.01% 3086
2023
Q2
$1.76K Hold
46
﹤0.01% 3128
2023
Q1
$1.88K Buy
46
+17
+59% +$710 ﹤0.01% 3045
2022
Q4
$36 Buy
+29
New +$1.01K ﹤0.01% 3515
2017
Q3
Sell
-670
Closed -$45.7K 386
2017
Q2
$45.7K Buy
+670
New +$45.6K 0.01% 549

Other funds holding ADNT

NewEdge Advisors's ADNT Position: Q2 2026 in Review

NewEdge Advisors reduced its Adient (ADNT) stake by 89% in Q2 2026, selling an estimated $363 and leaving 2 shares worth $37. The position accounts for ﹤0.01% of the portfolio, ranked #4158.

NewEdge Advisors first reported a position in ADNT in Q2 2017 and has held it in 16 quarters since. The position peaked at $45.7K in Q2 2017. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • NewEdge Advisors held 2 shares of Adient worth $37 as of Q2 2026.
  • NewEdge Advisors sold 17 Adient shares in Q2 2026, an estimated $363.
  • Adient made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #4158 holding.
  • NewEdge Advisors first reported a position in Adient in Q2 2017 and has held it in 16 quarters since.
  • NewEdge Advisors's Adient position peaked at $45.7K in Q2 2017.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.